Table 2

Baseline characteristics according to occurrence of an incident CVD event (coronary event, stroke, peripheral vascular event) and progression in renal status (defined as any increase in albuminuria level or progression to ESRD) during follow-up

Incident CVD eventProgression in renal status
EventNo eventProgressorsNonprogressors
N2692,6983732,830
Age (years)49 ± 10*37 ± 1239 ± 1238 ± 13
Age at onset (years)17 ± 1117 ± 1115 ± 1117 ± 11
HbA1c (%)8.8 ± 1.6*8.4 ± 1.59.4 ± 1.78.3 ± 1.4
Total cholesterol (mmol/L)5.3 ± 1.2*4.9 ± 0.95.4 ± 1.34.9 ± 0.9
SBP (mmHg)148 ± 20*132 ± 17141 ± 21132 ± 17
DBP (mmHg)81 ± 10*79 ± 1083 ± 1079 ± 10
PP (mmHg)66 ± 18*52 ± 1458 ± 1854 ± 15
Mean arterial pressure (mmHg)90 ± 10*83 ± 989 ± 1083 ± 9
History of CVD (%)34*5127
History of smoking (%)60*406139
Antihypertensive medication (%)77*316035
eGFR (mL/min/1.73 m2)57 ± 33*90 ± 3168 ± 4188 ± 32
Diabetic nephropathy59*15NANA
  • Values are expressed as number, means ± SD, or percentage.

  • Patients with a kidney transplant are excluded from the CVD analysis.

  • eGFR, estimated glomerular filtration rate; NA, not applicable.

  • *P < 0.05 vs. no event.

  • P < 0.05 vs. nonprogressors.